BDBM50262695 CHEMBL4071187
SMILES: O[C@H]([C@@H](O)C(O)=O)C(O)=O.NC(=N)NC(=O)Cc1cccc(CCc2cnc(nc2)N2CCOCC2)c1.NC(=N)NC(=O)Cc1cccc(CCc2cnc(nc2)N2CCOCC2)c1
InChI Key: InChIKey=CTMHWNLKSPWXPB-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM50262695![]() (CHEMBL4071187) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan. Electronic address: susumu.yamaki@astellas.com. Curated by ChEMBL | Assay Description Inhibition of human VAP-1 expressed in CHO cells preincubated for 20 mins followed by [14C]-benzylamine addition measured after 1 hr by scintillation... | Bioorg Med Chem 25: 6024-6038 (2017) Article DOI: 10.1016/j.bmc.2017.09.036 BindingDB Entry DOI: 10.7270/Q2B27XR3 | |||||||||||
More data for this Ligand-Target Pair |